NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Brigham and Women's Rheumatoid Arthritis Sequential Study
Brigham and Women's Rheumatoid Arthritis Sequential Study
Active Not RecruitingN/A
Sponsor: Brigham and Women's Hospital
Conditions: Rheumatoid Arthritis
Countries: United States
The goal of the present study is to establish a prospective observational cohort of Rheumatoid Arthritis patients in order to 1. Determine and validate biomarkers that predict drug response and toxicity in RA. 2. Determine and validate biomarkers that predict disease activity and prognosis in RA. 3. Evaluate the natural history of treated RA in terms of its clinical, functional and economic outcomes.
Eligibility overview
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Eligibility criteria
Inclusion Criteria: 1. Are 18 years of age or older; 2. Are a patient registered at the R.B.Brigham Arthritis Center. 3. Have, at the time of enrollment a diagnosis of RA made by a board certified rheumatologist. 4. Are able and willing to provide informed consent. Exclusion Criteria: * less than 18 years of age * do not have a diagnosis of RA * have a history of SLE or Psoriasis
Locations (1)
- Boston, Massachusetts, United States